| CAS NO: | 186610-88-8 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | hVEGF-IN-2 (compound 19) is a selectiveVEGF(Flk-1)receptor tyrosine kinases(RTK) inhibitor with anIC50value of 2.5 μM. hVEGF-IN-2 inhibitsPDGFRTK activity with anIC50value of 33.1 μM. hVEGF-IN-2 can be used for the development of RTK-specific drugs[1]. | ||
| IC50& Target |
| ||
| 体外研究 (In Vitro) | hVEGF-IN-2 (0-100 μM) shows the inhibitory activities to particular RTKs at the cellular level with IC50values of 2.5, 33.1, >100, >100 and >100 nM for VEGF, PDGF, EGF, HER-2 and IGF-1, respectively[1]. | ||
| 分子量 | 306.36 | ||
| Formula | C19H18N2O2 | ||
| CAS 号 | 186610-88-8 | ||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
